Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-17, Stock:NVS, The news for the past five days is as follows:
2018-05-10: NEWS1: Novartis CEO tells employees 'we made a mistake' on Cohen....NEWS2: Novartis CEO Calls Hiring of Trump Lawyer Michael Cohen a ‘Mistake’.NEWS3: Novartis CEO: ‘We Made a Mistake’ in Agreement With Trump Lawyer.NEWS4: Novartis CEO tells employees 'we made a mistake' in making deal with Trump lawyer Michael Cohen.NEWS5: Trump's attorney reportedly received payments from AT&T, Novartis.NEWS6: Insight or influence? Trump attorney's business scrutinized.NEWS7: Insight or influence? Trump attorney's business scrutinized.NEWS8: AT&T, foreign corporations risk legal liability for payments to Michael Cohen firm.NEWS9: Novartis Payments To Trump's Personal Attorney Cast A Cloud Over All Of Biopharma.NEWS10: [$$] Daily briefing: Malaysia election shock, Italian breakthrough, Uber flying taxi.NEWS11: Vice President Pence tells special counsel Mueller: 'It's time to wrap it up'.NEWS12: AT&T, Novartis Ties to Cohen Show Push for Trump Insights.NEWS13: AT&T, Novartis Ties to Cohen Reveal Backdoor Bids to Reach Trump.NEWS14: [$$] Daily briefing: Malaysia’s election shock, RBS’s $4.9bn settlement, fairytale Brexit.NEWS15: [$$] Novartis and AT&T Bet $1.8 Million on Cohen’s Policy Advice.NEWS16: Michael Cohen&apos;s lawyers say report alleging payments had &apos;numerous inaccurate statements&apos;.NEWS17: Michael Cohen's lawyers say report alleging payments had 'numerous inaccurate statements'.NEWS18: Companies detail payments to Trump lawyer; Daniels' attorney says there's more.
2018-05-11: NEWS1: An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYADâ€¦).NEWS2: An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYADâ€¦).NEWS3: White House: AT&T's payments to Trump lawyer Michael Cohen 'the definition of draining the swamp'.NEWS4: FDA expands use of Novartis MS drug to pediatric patients.NEWS5: Trump's 'Sweeping' Drug-Price Plan Comes Up Short.NEWS6: Lenvima Is Expected to Boost Merck’s Oncology Portfolio in 2018.NEWS7: Senator Wyden Wants to Know What Novartis Was Seeking From Cohen Deal.NEWS8: Novartis CEO Calls Trump Lawyer Payment 'Mistake'.NEWS9: AT&T CEO says hiring Trump lawyer Michael Cohen was a &apos;big mistake&apos;.NEWS10: AT&T CEO: Hiring Michael Cohen Was A "Big Mistake".NEWS11: AT&T CEO: Hiring Michael Cohen Was A "Big Mistake".NEWS12: Trade Wars, AT&T's Cohen Drama and Nvidia's Big Beat - 5 Things You Must Know.NEWS13: ‘Yesterday Was Not a Good Day.’ Novartis CEO Says Hiring Trump Lawyer Michael Cohen Was a Mistake.NEWS14: Q&A: Cohen's ties to Trump, corporate clients pose questions.NEWS15: Fosun Pharma to Vie for $2 Billion Novartis Portfolio.NEWS16: [$$] AT&T chief executive says hiring Trump lawyer was ‘big mistake’.NEWS17: [$$] Novartis CEO Calls Hiring of Trump Lawyer Michael Cohen a ‘Mistake’.NEWS18: [$$] AT&T boss says hiring Cohen was ‘big mistake’.
2018-05-14: NEWS1: Democrats demand answers from AT&T and Novartis about pay....NEWS2: Democratic senators demand answers from AT&T and Novartis about payments to Trump lawyer Cohen's company.NEWS3: Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents.NEWS4: Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents.NEWS5: Teva’s Copaxone Maintains Market Share amid Intense Competition.NEWS6: Novartis’s Cohen Payment Is Subject of Swiss Prosecutor Talks.NEWS7: Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents.NEWS8: The Swiss Stock Market Clung To A Small Increase On Pharma Strength.NEWS9: The Swiss Stock Market Clung To A Small Increase On Pharma Strength.NEWS10: [$$] Novartis' Gilenya Drug Approved.NEWS11: [$$] Novartis draws attention of Swiss prosecutors over Michael Cohen deal.NEWS12: [$$] Novartis's Gilenya Gets FDA Pediatric Approval.NEWS13: [$$] Greek consultant sues health minister and deputy.
2018-05-15: NEWS1: Novartis Completes Acquisition Of AveXis.NEWS2: Novartis Completes Acquisition Of AveXis.NEWS3: Health Care Sector Update for 05/15/2018: NVS,JNJ,XENE,TPIV,CRON.NEWS4: Health Care Sector Update for 05/15/2018: NVS,JNJ,XENE,TPIV,CRON.NEWS5: Novartis successfully completes acquisition of AveXis, Inc..NEWS6: Momenta Pharmaceuticals Contemplates Its Future.NEWS7: Momenta Pharmaceuticals Contemplates Its Future.NEWS8: Momenta Pharmaceuticals Contemplates Its Future.NEWS9: AstraZeneca’s 1Q18 Earnings: Analysts’ Estimates.NEWS10: Novartis CEO Is Said to Dial Up 5,000 Managers After Cohen Furor.NEWS11: How Did Bausch + Lomb Perform in 1Q18?.NEWS12: An Update on Teva’s Highly Anticipated Migraine Drug.NEWS13: The Swiss Stock Market Finished With A Slight Decrease.NEWS14: The Swiss Stock Market Finished With A Slight Decrease.NEWS15: Swiss prosecutors eye Novartis's deal with Cohen: reports.NEWS16: Novartis completes tender offer for all outstanding shares of AveXis, Inc..NEWS17: Novartis To Initiate Proof Of Concept Study With Cosentyx - Quick Facts.NEWS18: Novartis To Initiate Proof Of Concept Study With Cosentyx - Quick Facts.
2018-05-16: NEWS1: Novartis General Counsel Out Over Cohen Contract.NEWS2: Novartis General Counsel Out Over Cohen Contract.NEWS3: Here’s how Novartis’s former CEO explained hiring Michael Cohen.NEWS4: How Trump's Fix-It Man Became a $1.2 Million Headache for Novartis.NEWS5: How Trump's Fix-It Man Became a $1.2 Million Headache for Novartis.NEWS6: Eli Lilly's Cluster Headache Candidate Succeeds in Phase III.NEWS7: Eli Lilly's Cluster Headache Candidate Succeeds in Phase III.NEWS8: Pfizer Gets FDA Nod for Amgen, J&J's Anemia Drug Biosimilar.NEWS9: Pfizer Gets FDA Nod for Amgen, J&J's Anemia Drug Biosimilar.NEWS10: VT, NSRGY, NVS, RY: Large Inflows Detected at ETF.NEWS11: VT, NSRGY, NVS, RY: Large Inflows Detected at ETF.NEWS12: Novartis top lawyer exits over Trump attorney deal 'mistake'.NEWS13: Novartis Lawyer to Step Down After Cohen Payments.NEWS14: Analysts’ Recommendations for AstraZeneca as of May 15.NEWS15: Teva Stock Up 5% as Buffett's Berkshire Raises Stake in Q1.NEWS16: Teva Stock Up 5% as Buffett's Berkshire Raises Stake in Q1.NEWS17: Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million.NEWS18: Novartis general counsel resigns over deal with Trump lawyer.NEWS19: Novartis general counsel resigns over deal with Trump lawyer.NEWS20: Novartis Is on a Journey.NEWS21: Novartis ex-CEO says regrets hiring, not firing Trump lawyer.NEWS22: AstraZeneca’s 1Q18 Estimates: CVMD Products.NEWS23: Top Novarits lawyer exits over Trump attorney deal error.NEWS24: The Swiss Stock Market Pulled Back As Bank Stocks Dropped.NEWS25: The Swiss Stock Market Pulled Back As Bank Stocks Dropped.NEWS26: Novartis ex-CEO says regrets hiring, not firing Trump lawyer.NEWS27: Stocks are set to fall at the open after Dow ends 8-day win streak.NEWS28: Stocks are set to fall at the open after Dow ends 8-day win streak.NEWS29: Novartis Now Is Subject to Michael Cohen-Related Probes on 2 Continents.NEWS30: Top Novartis lawyer exits over Trump attorney deal error.NEWS31: Top Novartis Lawyer Exits Over the $1.2 Million It Paid to Trump Lawyer Michael Cohen.NEWS32: [$$] Novartis Lawyer Departs in Relation to Cohen Payments.NEWS33: [$$] Novartis Lawyer Retires in Relation to Cohen Payments.NEWS34: [$$] Novartis: Counsel Resigns Over Company's Michael Cohen Deal.NEWS35: [$$] Novartis general counsel retires in wake of Cohen payments.NEWS36: [$$] Novartis’s top lawyer retires in wake of Cohen payments.NEWS37: Novartis General Counsel to Step Down After Cohen Payments.NEWS38: Novartis Says General Counsel to Retire After Cohen Payments.NEWS39: Trump Lawyer Cohen Dangled Policy Help, Ex-Novartis Chief Says.NEWS40: [$$] Top Novartis lawyer quits after payments to Trump aide.NEWS41: Novartis: Positioned To Deliver Sales Growth, Margin Expansion Through 2022.NEWS42: Novartis: Positioned To Deliver Sales Growth, Margin Expansion Through 2022.NEWS43: Novartis Group General Counsel Felix Ehrat To Retire On June 1 - Quick Facts.NEWS44: Novartis Group General Counsel Felix Ehrat To Retire On June 1 - Quick Facts.

Answer: Decrease